Results for tag: "D2 Agonist"

The D2 Agonist market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. D2 Agonists are a type of drug that activate dopamine receptors in the brain, which can help to reduce symptoms of conditions such as schizophrenia, bipolar disorder, and depression. These drugs are typically administered orally, and can be used in combination with other medications. Common side effects of D2 Agonists include nausea, dizziness, and drowsiness. Some companies in the D2 Agonist market include Eli Lilly, Pfizer, and Novartis. These companies produce a variety of D2 Agonists, including aripiprazole, quetiapine, and risperidone. Other companies, such as Sun Pharmaceuticals and Dr. Reddy's Laboratories, also produce generic versions of these drugs. Show Less Read more